Wellcome

Stem Cell-based Therapy for Neurodegenerative Diseases [electronic resource] / edited by Fabin Han, Pengzhe (Paul) Lu.

Contributor(s): Han, Fabin [editor.] | Lu, Pengzhe (Paul) [editor.] | SpringerLink (Online service)Material type: TextTextSeries: Advances in Experimental Medicine and Biology ; 1266Publisher: Singapore : Springer Singapore : Imprint: Springer, 2020Edition: 1st ed. 2020Description: V, 145 p. 20 illus., 19 illus. in color. online resourceContent type: text Media type: computer Carrier type: online resourceISBN: 9789811543708Subject(s): Stem cells | Neurosciences | Neurology  | Stem Cells | Neurosciences | NeurologyAdditional physical formats: Printed edition:: No title; Printed edition:: No title; Printed edition:: No titleDDC classification: 571.6 LOC classification: QH588.S83Online resources: Click here to access online
Contents:
Chapter 1: General Introduction -- Chapter 2: Clinical-grade stem cells for the treatment of neurodegenerative diseases -- Chapter 3: Stem cell treatment for Parkinson's disease -- Chapter 4: Stem cell treatment for Alzheimer's disease -- Chapter 5: Stem cell treatment for Huntington's disease -- Chapter 6: Stem cell treatment for amyotrophic sclerosis disease -- Chapter 7: Stem cell treatment for multiple sclerosis -- Chapter 8: Stem cell treatment for muscular dystrophy -- Chapter 9: Stem cell treatment for spinal muscular atrophy -- Chapter 10: Stem cell treatment for Retinal Degeneration -- Chapter 11: Conclusion and future perspective.
In: Springer Nature eBookSummary: This book reviews the state-of-the-art in stem-cell-based therapies for neurodegenerative diseases, and highlights advances in both animal models and clinical trials. It comprehensively discusses most neurodegenerative diseases, including such as Parkinson's, Alzheimer's and Huntington's diseases, amyotrophic sclerosis, multiple sclerosis, muscular dystrophy and retinal degeneration, in which stem cells could potentially be used for therapy in the future. It also addresses the challenges and problems relating to the translation of stem-cell-based therapies into treatments. As such, the book will appeal to research scientists, physicians, graduate students, and medical professionals in the field of stem cells, neuroscience, neurology, neurorestoratology and major neurological disorders.
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Holdings
Item type Current library Call number Status Date due Barcode
Ebooks Ebooks Mysore University Main Library
Not for loan

Chapter 1: General Introduction -- Chapter 2: Clinical-grade stem cells for the treatment of neurodegenerative diseases -- Chapter 3: Stem cell treatment for Parkinson's disease -- Chapter 4: Stem cell treatment for Alzheimer's disease -- Chapter 5: Stem cell treatment for Huntington's disease -- Chapter 6: Stem cell treatment for amyotrophic sclerosis disease -- Chapter 7: Stem cell treatment for multiple sclerosis -- Chapter 8: Stem cell treatment for muscular dystrophy -- Chapter 9: Stem cell treatment for spinal muscular atrophy -- Chapter 10: Stem cell treatment for Retinal Degeneration -- Chapter 11: Conclusion and future perspective.

This book reviews the state-of-the-art in stem-cell-based therapies for neurodegenerative diseases, and highlights advances in both animal models and clinical trials. It comprehensively discusses most neurodegenerative diseases, including such as Parkinson's, Alzheimer's and Huntington's diseases, amyotrophic sclerosis, multiple sclerosis, muscular dystrophy and retinal degeneration, in which stem cells could potentially be used for therapy in the future. It also addresses the challenges and problems relating to the translation of stem-cell-based therapies into treatments. As such, the book will appeal to research scientists, physicians, graduate students, and medical professionals in the field of stem cells, neuroscience, neurology, neurorestoratology and major neurological disorders.

There are no comments on this title.

to post a comment.

No. of hits (from 9th Mar 12) :

Powered by Koha